Maternal Foetal Medicine Unit - Mediclinic Middle East

We provide FMF-certified combined first-trimester screening between 11 and 14 weeks, including:

• Nuchal translucency measurement with FMF-accredited quality assurance
• Combined screening for trisomy 21, 18 and 13 using maternal biochemistry and ultrasound markers
• Pre-eclampsia risk assessment using FMF algorithm (uterine artery Doppler, MAP, PlGF, PAPP-A)
• Preterm birth risk evaluation
• Non-invasive prenatal testing (NIPT) coordination and counselling
• Early Foetal anatomical assessment

This structured approach enables early identification of high-risk pregnancies and supports timely preventive interventions.

Between 18 and 22 weeks, we perform a comprehensive Foetal anatomy scan following ISUOG and AIUM standards, including:

• Brain, face, spine, heart, chest, abdomen, kidneys and limbs
• Placental location and morphology
• Cervical length assessment
• Uterine artery Doppler for placental function

When abnormalities are identified, we provide detailed counselling, coordinate genetic testing and plan multidisciplinary postnatal care.

We offer specialised Foetal cardiac assessment for pregnancies at increased risk, including:

• Segmental cardiac anatomy evaluation
• Outflow tracts and three-vessel trachea view
• Cardiac Doppler and function assessment
• Foetal rhythm evaluation

Early diagnosis enables delivery planning in centres with appropriate neonatal cardiac support.

We provide structured, evidence-based monitoring for Foetal growth restriction (FGR), including:

• Serial Foetal biometry using WHO growth charts
• Umbilical artery, MCA and cerebroplacental ratio Doppler
• Ductus venosus Doppler and advanced monitoring for preterm FGR
• Uterine artery Doppler assessment
• sFlt-1/PlGF testing when clinically indicated
• Individualised delivery timing based on Doppler and gestation

We differentiate between SGA and true FGR using international criteria to ensure appropriate management.

Our maternal medicine specialised care for women with pre-existing medical conditions and pregnancy-related complications, integrating obstetric and medical expertise.

Pre-existing conditions include:

• Chronic hypertension
• Diabetes (pre-gestational and gestational)
• Autoimmune diseases (SLE, APS, rheumatoid arthritis)
• Thrombophilia
• Renal disease
• Cardiac disease in pregnancy
• Thyroid disorders
• Epilepsy
• Obesity and metabolic syndrome

Pregnancy-related conditions include:

• Pre-eclampsia and HELLP syndrome
• Gestational diabetes
• Intrahepatic cholestasis
• Placenta praevia and accreta spectrum
• Venous thromboembolism
• Anaemia in pregnancy
• Recurrent pregnancy loss

All care is coordinated with relevant subspecialties to ensure comprehensive management.

We manage a wide range of complex pregnancy conditions, including:

• Multiple pregnancies with chorionicity-based monitoring
• Twin complications (TTTS, sFGR, TAPS)
• Foetal anaemia and intrauterine transfusion
• Preterm birth risk management
• Pregnancy after previous adverse outcomes
• Foetal structural abnormalities
• Alloimmunisation (Rh and other antibodies) 

We provide the full range of ultrasound-guided diagnostic procedures:

• Chorionic villus sampling (CVS) from 11 weeks
• Amniocentesis from 15 weeks
• Cordocentesis (Foetal blood sampling)

All procedures include counselling, real-time ultrasound guidance and post-procedure monitoring.

Our in-house Foetal therapies include:

• Intrauterine blood transfusion
• Amnioreduction
• Therapeutic amnioinfusion
• Foetal shunt placement
• Intrauterine vascular procedures
• Cord occlusion in selected cases 

We offer advanced Foetal surgical interventions performed by our subspecialist team:

• Fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome (TTTS)
• Prenatal repair of spina bifida (myelomeningocele)
• Fetoscopic endoluminal tracheal occlusion (FETO) for congenital diaphragmatic hernia

These procedures are offered based on strict clinical criteria and international evidence to improve outcomes.

We support women planning pregnancy by:

• Reviewing medical and obstetric history
• Identifying recurrence risks
• Optimising chronic conditions
• Planning preventive strategies (aspirin, progesterone, cerclage)
• Coordinating genetic counselling 

We provide access to comprehensive prenatal genetic services:

• Non-invasive prenatal testing (NIPT)
• Chromosomal microarray analysis (CMA)
• Targeted gene panels and whole exome sequencing
• Carrier screening

All results are explained clearly with personalised management plans.

• Structured reports shared with referring physicians
• Defined follow-up and surveillance plans
• Advanced delivery planning
• Neonatal team coordination when required